Root Financial Partners
SNDX icon

Root Financial Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

Root Financial Partners’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$320 Buy
+17
New +$343 ﹤0.01% 3382
2026
Q2 		– Sell
-171
Closed -$4K – 2756
2026
Q1 		$4K Buy
+171
New +$3.72K ﹤0.01% 2034

Other funds holding SNDX

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return
Aisling Capital Management
Aisling Capital Management New York $299M AUM 39.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Root Financial Partners's SNDX Position: Q3 2026 in Review

Root Financial Partners opened a new position in Syndax Pharmaceuticals (SNDX) in Q3 2026: 17 shares worth $320. The stake represents ﹤0.01% of the portfolio and ranks #3382 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in SNDX as recently as Q1 2026.

Root Financial Partners first reported a position in SNDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $4K in Q1 2026. 129 funds tracked by Wall St. Rank hold SNDX as of Q3 2026.

  • Root Financial Partners held 17 shares of Syndax Pharmaceuticals worth $320 as of Q3 2026.
  • Syndax Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3382 holding.
  • Root Financial Partners first reported a position in Syndax Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • Root Financial Partners's Syndax Pharmaceuticals position peaked at $4K in Q1 2026.
  • 129 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.